MDM2 overexpression does not account for stabilization of wild-type p53 protein in non-Hodgkin's lymphomas

Blood

Volumn 85, Issue 11, 1995, Pages 3239-3246

  Maestro, Roberta ^b   Gloghini, Annunziata ^b   Doglioni, Claudio ^b   Gasparotto, Daniela ^b   Vukosavljevic, Tamara ^b   De Re, Valli ^b   Laurino, Licia ^b   Carbone, Antonino ^b   Boiocchi, Mauro ^a  

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ONCOPROTEIN; PROTEIN P53;

ARTICLE; CANCER GROWTH; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; NONHODGKIN LYMPHOMA; ONCOGENE; PRIORITY JOURNAL; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE;

EID: 0029049621     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v85.11.3239.bloodjournal85113239     Document Type: Article

References (42)

1. Hollstein M, Sidransky D, Vogelstein B, Harris CC: p53 mutations in human cancers. Science 253:49, 1991
2. Levine AJ, Momand J, Finlay CA: The p53 tumor suppressor gene. Nature 351:543, 1991
3. Lane DP: p53, guardian of the genome. Nature 358:15, 1992
4. Bartek J, Iggo R, Gannon J, Lane DP: Genetic and immunohistochemical analysis of mutant p53 in human breast cancer cell lines. Oncogene 5:893, 1990
5. Halevy O, Hall A, Oren M: Stabilization of the p53 transformation-related protein in mouse fibrosarcoma cell lines: Effects of protein sequence and intracellular environment. Mol Cell Biol 9:3385, 1989
6. Iggo R, Gatter K, Bartek J, Lane D, Harris AL: Increased expression of mutant forms of p53 oncogene in primary lung cancer. Lancet 335:675, 1990
7. Maestro R, Dolcetti R, Gasparotto D, Doglioni C, Pelucchi S, Grandi E, Boiocchi M: High frequency of p53 gene alterations associated with protein overexpression in human squamous cell carcinoma of the larynx. Oncogene 7:1159, 1992
8. Marks JR, Davidoff AM, Kerns BJ, Humprey PA, Pence JC, Dodge RK, Clarke-Pearson DL, Iglehart JD, Bast RC, Berchuck A: Overexpression and mutations of p53 in epithelial ovarian cancer. Cancer Res 51:1979, 1991
9. Rodrigues NR, Rowan Am, Smith RE, Kerr IB, Bodmer WF, Gannon JV, Lane D: p53 mutations in colorectal cancer. Proc Natl Acad Sci USA 87:7555, 1990
10. Cesarman E, Chadburn A, Inghirami G, Gaidano G, Knowles DM: Structural and functional analysis of oncogenes and tumor suppressor genes in adult T-cell leukemia/lymphoma shows frequent p53 mutations. Blood 80:3205, 1992
11. Gaidano G, Ballerini P, Gong JC, Inghirami G, Neri A, Newcomb EW, Magrath IT, Knowles DM, Dalla-Favera R: p53 mutations in human lymphoid malignancies: Association with Burkitt lymphoma and chronic lymphocytic leukemia. Proc Natl Acad Sci USA 88:5413, 1991
12. Lo Coco F, Gaidano G, Louie DC, Offit K, Chaganti RSK, Dalla-Favera R: p53 mutations are associated with histologic transformation of follicular lymphoma. Blood 82:2289, 1993
13. De Re V, Gloghini A, De Vita S, Carbone A, Maestro R, Gasparotto D, Vukosavljevic T, Boiocchi M: p53 protein over-expression and p53 gene abnormalities in HIV-1-related non-Hodgkin's lymphomas. Int J Cancer 56:662, 1994
14. Doglioni C, Pelosio P, Mombello A, Scarpa A, Chilosi M: Immunohistochemical evidence of abnormal expression of the anti-oncogene-encoded p53 phosphoprotein in Hodgkin's disease and CD30+ anaplastic lymphomas. Hematol Pathol 5:67, 1991
15. Said JW, Barrera R, Shintaku P, Nakamura H, Koeffler HP: Immunohistochemical analysis of p53 expression in malignant lymphomas: Am J Pathol 141:1343, 1992
16. Soini Y, Paakko P, Alavaikko M, Vahakangas K: p53 expression in lymphatic malignancies. J Clin Pathol 45:1011, 1992
17. Villuendas R, Piris MA, Orradre JL, Mollejo M, Algara P, Sanchez L, Martinez JC, Martinez P: p53 protein expression in lymphomas and reactive lymphoid tissues. J Pathol 5:67, 1991
18. Kastan MB, Radin AI, Kuerbitz SJ, Onyekwere O, Wolkow CA, Civin CI, Stone KD, Woo T, Ravindranath Y, Craig RW: Levels of p53 protein increase with maturation in human hematopoietic cells. Cancer Res 51:4279, 1991
19. Rivas CI, Wisniewsky D, Strife A, Perez A, Lambek C, Bruno S, Darzynkiewicz Z, Clarkson B: Constitutive expression of p53 protein in enriched normal human marrow blast cell population. Blood 79:1982, 1992
20. Lane DP, Crawford LV: T antigen is bound to a host protein in SV40-transformed cells. Nature 278:261, 1979
21. Sarnow P, Ho YS, Williams J, Levine AJ: Adenovirus E1B-58Kd tumor antigen and SV40 large tumor antigen are physically associated with the same 54Kd cellular protein in transformed cells. Cell 28:387, 1982
22. Fakharzadeh SS, Trusko SP, George DL: Tumorigenic potential associated with enhanced expression of a gene that is amplified in a mouse tumor cell line. EMBO J 10:1565, 1991
23. Martinez JI, Georgoff J, Martinez J, Levine AJ: Cellular localization and cell cycle regulation by a temperature sensitive p53 protein. Genes Dev 5:151, 1991
24. Momand J, Zambetti GP, Olson DC, George D, Levine AJ: The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53 mediated transactivation. Cell 69:1237, 1992
25. Oliner JD, Kinzler KW, Meltzer PS, George DL, Vogelstein B: Amplification of a gene encoding a p53-associated protein in human sarcomas. Nature 358:80, 1992
26. Carbone A, Gloghini A, Volpe R, Pinto A: KP1 (CD68)-positive large cell lymphomas: A histopathologic and immunophenotypic characterization of 12 cases. Hum Pathol 24:886, 1993
27. The non-Hodgkin's lymphoma pathologic classification project. National Cancer Institute sponsored study of classification of non-Hodgkin's lymphomas. Summary and description of a working formulation for clinical usage. Cancer 49:2112, 1982
28. Stein H: Ki-1-anaplastic large cell lymphoma: Is it a descrete entity? Leuk Lymphoma 10:81, 1993 (suppl)
29. Agnarsson BA, Kadin ME: Ki-1-positive large cell lymphoma: A morphologic and immunologic study of 19 cases. Am J Surg Pathol 12:264, 1988
30. Leach FS, Tokino T, Meltzer P, Burrel M, Oliner JD, Smith S, Hill DE, Sidransky D, Kinzler KW, Vogelstein B: p53 mutation and MDM2 amplification in human soft tissue sarcomas. Cancer Res 53:2231, 1993
31. Hsu SM, Raine L, Fanger H: A comparative study of the peroxidase-antiperoxidase method and an avidin-biotin complex method for studying polypeptide hormones with radioimmunoassay. Am J Clin Pathol 75:734, 1981
32. Cordell JL, Falini B, Erber WN, Ghosh AK, Abdulaziz Z, MacDonald S, Pulford KAF, Stein H, Mason DY: Immunoenzymatic labelling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal antialkaline phosphatase (APAAP complexes). J Histochem Cytochem 32:219, 1984
33. Sambrook J, Fritsch EF, Maniatis T: Molecular Cloning. A Laboratory Manual. Plainview, NY, Cold Spring Harbor Laboratory, 1989
34. Wolf D, Laver-Rudik Z, Rotter V: In vitro expression of human p53 cDNA clones and characterization of the cloned human gene. Mol Cell Bio 5:1887, 1985
35. Cesarman E, Inghirami G, Chadburn A, Knowles DM: High levels of p53 protein expression do not correlate with p53 gene mutations in anaplastic large cell lymphoma. Am J Pathol 143:845, 1993
36. Villuendas R, Piris MA, Algara P, Sanchez-Beato M, Sanchez-Verde L, Martinez JC, Orradre JL, Garcia P, Lopez C, Martinez P. The expression of p53 protein in non-Hodgkin's lymphomas is not always dependent on p53 gene mutations. Blood 82:3151, 1993
37. Oliner JD, Pietenpol JA, Thiagalingam S, Gyuris J, Kinzler KW, Vogelstein B: Oncoprotein MDM2 conceals the activation domain of tumor suppressor p53. Nature 362:857, 1993
38. Cesarman E, Liu YF, Knowles DM: The MDM2 oncogene is rarely amplified in human lymphoid tumors and does not correlate with p53 gene expression. Int J Cancer 56:457, 1994
39. Wu X, Bayle JH, Olson D, Levine AJ: The p53-mdm2 autoregulatory feedback loop. Genes Dev 7:1126, 1993
40. Picksley SM, Lane DP: The p53-autoregolatory feedback loop: A paradigm for the regulation of growth control by p53? BioEssay 15:689, 1993
41. Sander CA, Yano T, Clark HM, Harris C, Longo DL, Jaffe ES, Raffeld M: p53 mutation is associated with progression in follicular lymphomas. Blood 82:1994, 1993
42. Buenos-Ramos CE, Yang Y, de Leon E, McCown P, Stass SA, Albitar M: The human MDM-2 oncogene is overexpressed in leukemias. Blood 82:2617, 1993